Now we have (finally) seen a firm order for IV relenza, and the price at around 10x the inhaled version, will GSK ramp up production of IV to be distributed around the world's hospitals? They can save more lives now... a good outcome for humanity.
Add to My Watchlist
What is My Watchlist?